"10.1371_journal.pone.0053531","plos one","2013-01-07T00:00:00Z","Christiane Desel; Kerstin Werninghaus; Manuel Ritter; Katrin Jozefowski; Jens Wenzel; Norman Russkamp; Ulrike Schleicher; Dennis Christensen; Stefan Wirtz; Carsten Kirschning; Else Marie Agger; Clarissa Prazeres da Costa; Roland Lang","Institute of Clinical Microbiology, Immunology and Hygiene, University Hospital Erlangen, Erlangen, Germany; Institute of Medical Microbiology, Immunology and Hygiene, Technische Universität München, Munich, Germany; Statens Serum Institut, Department of Infectious Disease Immunology, Copenhagen, Denmark; Medical Clinic 1, Gastroenterology, Pneumology and Endocrinology, University Hospital Erlangen, Erlangen, Germany; Institut für Medizinische Mikrobiologie, Essen, Germany","Conceived and designed the experiments: CD KW RL. Performed the experiments: CD KW MR KJ NR JW. Analyzed the data: CD KW RL JW. Contributed reagents/materials/analysis tools: US DC SW CK EMA CPdC. Wrote the paper: CD MR CPdC RL.","CAF01 is currently in clinical development at Statens Serum Institut and three clinical phase 1 studies have been conducted successfully. With regards to the intellectual property status on CAF01, the Statens Serum Institut has one issued patent (WO2006002642). None of the coauthors are registered as inventors on the patent and the full right has been transferred to Statens Serum Institut. EMA and/or DC are furthermore coinventors on patents on related technologies (WO2005004911A2, WO2009003474, WO2010054654, PCT/DK2012/000080) for all of which the full right has been transferred to Statens Serum Institut. This does not alter the authors adherence to the PLOS ONE policies on sharing data and materials.","2013","01","Christiane Desel","CD",13,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
